Use of Vedolizumab in Inflammatory Bowel Disease: A Single-Center Experience
Use of Vedolizumab in Inflammatory Bowel Disease: A Single-Center Experience
About this item
Full title
Author / Creator
Publisher
AVES
Journal title
Language
English
Formats
Publication information
Publisher
AVES
Subjects
More information
Scope and Contents
Contents
Background: Vedolizumab, which is a monoclonal antibody that selectively binds to [alpha]4[beta]7 integrin in the gastrointestinal system, may be an effective and safe treatment alternative in those with anti-tumor necrosis factor-resistant inflammatory bowel disease. Methods: Patients administered vedolizumab due to anti-tumor necrosis factor resi...
Alternative Titles
Full title
Use of Vedolizumab in Inflammatory Bowel Disease: A Single-Center Experience
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_6290d8a45e9547df848a11305bb93d7d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6290d8a45e9547df848a11305bb93d7d
Other Identifiers
ISSN
1300-4948
E-ISSN
2148-5607
DOI
10.5152/tjg.2022.21684
